Jianli Wang

发表

Effect of granulocyte colony-stimulating factor priming combined with low-dose cytarabine and homoharringtonine in higher risk myelodysplastic syndrome patients.

Liu-fang Gu, Wang-gang Zhang, Fangxia Wang, 2016, Leukemia research.

Anti-tumor immune responses in immune-reconstituted mice injected with a tumor vaccine

Wanggang Zhang, A. He, Yun Yang, 2012, Medical Oncology.

Expression profile analysis of long non‐coding RNA in acute myeloid leukemia by microarray and bioinformatics

Tian Liu, Liu-fang Gu, Fangxia Wang, 2018, Cancer science.

Detection of serum tumor markers in multiple myeloma using the CLINPROT system

Juan Yang, Wanggang Zhang, A. He, 2012, International Journal of Hematology.

Prediction and identification of HLA-A*0201-restricted epitopes from leukemia-associated protein MLAA-22 which elicit cytotoxic T lymphocytes

Wanggang Zhang, Jing Li, Liu-fang Gu, 2014, Medical Oncology.

Granulocyte colony stimulating factor priming chemotherapy is more effective than standard chemotherapy as salvage therapy in relapsed acute myeloid leukemia

Wanggang Zhang, Fangxia Wang, Xing-mei Cao, 2018, Medicina Clínica (English Edition).

Granulocyte colony stimulating factor priming chemotherapy is more effective than standard chemotherapy as salvage therapy in relapsed acute myeloid leukemia.

Wanggang Zhang, Fangxia Wang, Xing-mei Cao, 2017, Medicina clinica.

Serum platelet factor 4 is a promising predictor in newly diagnosed patients with multiple myeloma treated with thalidomide and VAD regimens

Wanggang Zhang, Fangxia Wang, A. He, 2019, Hematology.

Comparison of porcine anti‐human lymphocyte globulin and rabbit anti‐human thymocyte globulin in the treatment of severe aplastic anemia: a retrospective single‐center study

Wanggang Zhang, Xing-mei Cao, Yin-xia Chen, 2016, European journal of haematology.

Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)

Saijuan Chen, Hua Jiang, Jian-yong Li, 2022, Journal of Hematology & Oncology.

A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma

B. Lei, Y. Geng, Zong-fang Li, 2018, Journal of Hematology & Oncology.

Identification and functional characterization of the novel acute monocytic leukemia associated antigen MLAA-34

Wen-Bin Li, A. He, Jianli Wang, 2009, Cancer Immunology, Immunotherapy.

Focusing on long non‐coding RNA dysregulation in newly diagnosed multiple myeloma

Yan Peng, Fangxia Wang, A. He, 2018, Life sciences.

Potential biomarkers for adult acute myeloid leukemia minimal residual disease assessment searched by serum peptidome profiling

Juan Yang, Wanggang Zhang, A. He, 2013, Proteome Science.

Infusion of leukocytes from HLA haplo-identical familial donors as an adjuvant in the HLH-2004 protocol to treat the virus-associated adult hemophagocytic lymphohistiocytosis: a retrospective study of 26 patients

Yang Zhang, Wanggang Zhang, A. He, 2018, Annals of Hematology.

High-Intensity Chemotherapy is Associated with Better Prognosis in Young Patients with High-Risk Diffuse Large B-Cell Lymphoma: A 10-Year Single-Center Retrospective Cohort Study

Wanggang Zhang, Xing-mei Cao, Yin-xia Chen, 2016, Medical science monitor : international medical journal of experimental and clinical research.

Chimeric Antigen Receptor T Cell Therapy in the Relapsed or Refractory Multiple Myeloma with Extramedullary Disease--a Single Institution Observation in China

B. Lei, Liu-fang Gu, Fangxia Wang, 2020 .

Identification of HLA-A*0201-restricted CTL Epitopes for MLAA-34-specific Immunotherapy for Acute Monocytic Leukemia

Wanggang Zhang, Fangxia Wang, A. He, 2021, Journal of immunotherapy.

Circ-ANAPC7 is Upregulated in Acute Myeloid Leukemia and Appears to Target the MiR-181 Family

Yuqiang Ji, Tian Liu, Juan Yang, 2018, Cellular Physiology and Biochemistry.

Updated Analysis of a Phase 1, Open-Label Study of LCAR-B38M, a Chimeric Antigen Receptor T Cell Therapy Directed Against B-Cell Maturation Antigen, in Patients with Relapsed/Refractory Multiple Myeloma

Zong-fang Li, B. Lei, Y. Geng, 2018, Blood.

Combination chemotherapy with low‐dose cytarabine, homoharringtonine, and granulocyte colony‐stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia

Fangxia Wang, Xing-mei Cao, Yin-xia Chen, 2008, American journal of hematology.

Variability of serum novel serum peptide biomarkers correlates with the disease states of multiple myeloma

Fangxia Wang, A. He, Yun Yang, 2019, Clinical Proteomics.

Prokaryotic expression of MLAA-34 and generation of a novel human ScFv against MLAA-34 by phage display technology

Yang Zhang, Wanggang Zhang, A. He, 2017, Oncotarget.

Potential biomarkers for adult acute myeloid leukemia minimal residual disease assessment searched by serum peptidome profiling

Yang Zhang, Juan Yang, Wanggang Zhang, 2013, Proteome Science.

Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia

Yang Zhang, Juan Yang, Wanggang Zhang, 2014, Proteome Science.

Targeted silencing of genes related to acute monocytic leukaemia by CpG(B)-MLAA-34 siRNA conjugates

Wanggang Zhang, A. He, Xiao-rong Ma, 2019, Journal of drug targeting.

Long-Term Follow-up of a Phase 1, First-in-Human Open-Label Study of LCAR-B38M, a Structurally Differentiated Chimeric Antigen Receptor T (CAR-T) Cell Therapy Targeting B-Cell Maturation Antigen (BCMA), in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

B. Lei, Y. Geng, Zong-fang Li, 2019, Blood.

Dose-enhanced combined priming regimens for refractory acute myeloid leukemia and middle-and-high-risk myelodysplastic syndrome: a single-center, retrospective cohort study

B. Lei, Wanggang Zhang, Liu-fang Gu, 2016, OncoTargets and therapy.

Variability of serum novel serum peptide biomarkers correlates with the disease states of multiple myeloma

Fangxia Wang, A. He, Yun Yang, 2019, Clinical Proteomics.

Deregulated Expression of Long Non-Coding RNA AC092580.4 in Acute Myeloid Leukemia

Fangxia Wang, A. He, Baiyan Wang, 2018, Blood.

MLAA-34 knockdown shows enhanced antitumor activity via JAK2/STAT3 signaling pathway in acute monocytic leukemia

Yanping Zhang, B. Lei, Xin Meng, 2020, Journal of Cancer.

Five-year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR-B38M chimeric antigen receptor T cells in the LEGEND-2 study: a case report

Liu-fang Gu, Fangxia Wang, Xing-mei Cao, 2022, Journal of Medical Case Reports.